Repeated assessment of neuropsychological deficits in multiple sclerosis using the symbol digit modalities test and the MS neuropsychological screening questionnaire

Multiple Sclerosis

Volumn 14, Issue 7, 2008, Pages 940-946

  Benedict, Ralph H B ^a,b,e   Duquin, J A ^a,b   Jurgensen, S ^c   Rudick, R A ^d   Feitcher, J ^b   Munschauer, F E ^a,b   Panzara, M A ^c   Weinstock Guttman, B ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b JACOBS NEUROLOGICAL INSTITUTE   (United States)

^c BIOGEN   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

Cognition; Depression; Multiple sclerosis; Screening

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MS NEUROPSYCHOLOGICAL SCREENING QUESTIONNAIRE; MULTIPLE SCLEROSIS; PATIENT MONITORING; PREDICTION; PSYCHOPATHY; QUESTIONNAIRE; REGRESSION ANALYSIS; RELIABILITY; REPRODUCIBILITY; SCORING SYSTEM; SELF REPORT; SYMBOL DIGIT MODALITIES TEST; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; STANDARD; VALIDATION STUDY;

ADULT; COGNITION DISORDERS; DEPRESSION; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 54449101658     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508090923     Document Type: Article

References (43)

1. Rao SM Leo GJ Bernardin L Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-691.
2. Benedict RHB Cookfair D Gavett R. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12: 549-558.
3. Rao SM Leo GJ Ellington L. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991; 41: 692-696.
4. Beatty WW Blanco CR Wilbanks SL Paul RH. Demographic, clinical, and cognitive characteristics of multiple sclerosis patients who continue to work. J Neurol Rehabil 1995; 9: 167-173.
5. Benedict RHB Wahlig E Bakshi R. Predicting quality of life in multiple sclerosis: Accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005; 231: 29-34.
6. Langdon DW Thompson AJ. Multiple sclerosis: A preliminary study of selected variables affecting rehabilitation outcome. Mult Scler 1999; 5: 94-100.
7. Benedict RHB Shapiro A Priore RL. Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients. Mult Scler 2001; 6: 391-396.
8. Benedict RHB Priore RL Miller C. Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci 2001; 13: 70-76.
9. Benedict RHB Munschauer F Zarevics P. Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients. J Neurol (in press).
10. Krupp LB Christodoulou C Melville P. Donepezil improves memory in multiple sclerosis in a randomized clinical trial. Neurology 2004; 63: 1579-1585.
11. Smith A. Symbol Digit Modalities Test: Manual. Los Angeles: Western Psychological Services; 1982.
12. Benedict RHB Cox D Thompson LL. Reliable screening for neuropsychological impairment in MS. Mult Scler 2004; 10: 675-678.
13. Benedict RHB. Effects of using same vs. alternate form memory tests in short-interval, repeated assessment in multiple sclerosis. J Int Neuropsychol Soc 2005; 11: 727-736.
14. Houtchens MK Benedict RHB Killiany R. Thalamic atrophy and cognition in multiple sclerosis. Neurology. 2007; 69: 113-123.
15. Christodoulou C Krupp LB Liang Z. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology 2003; 60: 1793-1798.
16. Bermel RA Bakshi R Tjoa C. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 2002; 59: 275-280.
17. Benedict RHB Weinstock-Guttman B Fishman I. Prediction of neuropsychological impairment in multiple sclerosis: Comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004; 61: 226-230.
18. Benedict RHB Bruce JM Dwyer MG. Neocortical atrophy, third ventricular width, and cognitive dysfunciton in multiple sclerosis. Arch Neurol 2006; 63: 1301-1306.
19. Benedict RHB Zivadinov R. Predicting neuropsychological abnormalities in multiple sclerosis. J Neurol Sci 2006; 245: 67-72.
20. Parmenter BA Weinstock-Guttman B Garg N. Screening for cognitive impairment in MS using the Symbol Digit Modalities Test. Mult Scler 2006; 13: 52-57.
21. Carone D Benedict RHB Munschauer FE. Interpreting patient/informant discrepancies of reported cognitive symptoms in MS. J Int Neuropsychol Soc 2005; 11: 574-583.
22. Benedict RHB. Integrating cognitive function screening and assessment into the routine care of multiple sclerosis patients. CNS Spectr 2005; 10: 384-391.
23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Ann Neurol 1983; 13: 227-231.
24. McDonald WI Compston A Edan G. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
25. Lublin FD Reingold SC Lublin FD Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911 [see comment].
26. Benedict RHB Fischer JS Archibald CJ. Minimal neuropsychological assessment of MS patients: A consensus approach. Clin Neuropsychol 2002; 16: 381-397.
27. Benton AL Sivan AB Hamsher K. Contributions to neuropsychological assessment. 2nd ed. New York: Oxford University Press; 1994.
28. Delis DC Kramer JH Kaplan E Ober BA. California verbal learning test manual. 2nd ed, Adult Version. San Antonio, Texas: Psychological Corporation; 2000.
29. Benedict RHB. Brief visuospatial memory test - revised: Professional manual. Odessa, Florida: Psychological Assessment Resources, Inc; 1997.
30. Gronwall DMA. Paced auditory serial addition task: A measure of recovery from concussion. Percept Mot Skills 1977; 44: 367-373.
31. Rao SM. A manual for the brief, repeatable battery of neuropsychological tests in multiple sclerosis 1991.
32. Delis DC Kaplan E Kramer JH. Delis-Kaplan executive function system. San Antonio, Texas: Psychological Corporation; 2001.
33. Benedict RHB Fishman I McClellan MM. Validity of the Beck Depression Inventory - Fast Screen in multiple sclerosis. Mult Scler 2003; 9: 393-396.
34. Benedict RHB Munschauer FE Linn R. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler 2003; 9: 95-101.
35. Anastasi A. Psychological testing. 6th ed. Macmillan Publishing Company; 1988.
36. Iverson GL Lovell MR Collins MW. Interpreting change on ImPACT following sport concussion. Clin Neuropsychol 2003; 17: 460-467.
37. Amato MP Bartolozzi ML Zipoli V. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 2004; 63: 89-93.
38. Kahn RL. Memory complaint and impairment in the aged: The effect of depression and altered brain function. Arch Gen Psychiatry 1975; 32: 1569-1573.
39. Riege WH. Self-report and tests of memory aging. Clin Gerontol 1982; 1: 23-36.
40. Bruce JM Arnett PA. Self-reported everyday memory and depression in patients with multiple sclerosis. J Clin Exp Neuropsychol 2004; 26: 200-214.
41. O'Brien A Gaudino-Goering E Shawaryn M. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes. Arch Clin Neuropsychol 2007; 22: 933-948.
42. Rourke SB Halman MH Bassel C. Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning. J Clin Exp Neuropsychol 1999; 21: 737-756.
43. Elixhauser A Leidy NK Meador K. The relationship between memory performance, perceived cognitive function, and mood in patients with epilepsy. Epilepsy Res 1999; 37: 13-24.